Earnings per Share and Stock-Based Compensation (Tables)

9 Months Ended

Jul. 31, 2014

Earnings per Share and Stock Based Compensation [Abstract]

Reconciliation of Denominator of Each Net Loss per Share

The table below sets forth the reconciliation of the denominator of each net loss/income per share calculation for the third quarter and nine months ended July 31, 2014 and 2013:

	Three Months Ended July 31,		Nine Months Ended July 31,
In thousands	2014	2013	2014	2013
Shares used in computing basic net loss/income per share	170,794	167,624	170,337	166,735
Dilutive effect of stock options and restricted stock(1)	—	4,200	—	—
Dilutive effect of stock warrants(1)	—	18,744	—	—
Shares used in computing diluted net loss/income per share	170,794	190,568	170,337	166,735

(1) For the third quarter of fiscal 2014, the shares used in computing diluted net loss per share do not include 1,572,000 of dilutive stock options and shares of restricted stock, nor 14,950,000 of dilutive warrant shares, as the effect is anti-dilutive given the Company’s net loss from continuing operations. For the third quarter of fiscal 2014 and 2013, additional stock options outstanding of 5,710,000 and 5,763,000, respectively, and additional warrant shares outstanding of 10,704,000 and 6,910,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method. For the nine months ended July 31, 2014 and 2013, the shares used in computing diluted net loss per share do not include 2,922,000 and 4,016,000, respectively, of dilutive stock options and shares of restricted stock, nor 18,490,000 and 17,596,000, respectively, of dilutive warrant shares, as the effect is anti-dilutive given the Company’s net loss from continuing operations. For the nine months ended July 31, 2014 and 2013, additional stock options outstanding of 4,364,000 and 6,286,000, respectively, and additional warrant shares outstanding of 7,164,000 and 8,058,000, respectively, were excluded from the calculation of diluted EPS, as their effect would have been anti-dilutive based on the application of the treasury stock method.

Schedule of Activity Related to Performance Based Equity Instruments

Activity related to these performance-based equity instruments for the nine months ended July 31, 2014 was as follows:

	Performance Options		Performance Restricted Stock Units
Outstanding, October 31, 2013	688,000		11,675,782
Granted	—		300,000
Exercised	(12,000	)	—
Canceled	(36,000	)	(30,937	)
Outstanding, July 31, 2014	640,000		11,944,845

Schedule of Changes in Shares under Option, Excluding Performance Based Options

Changes in shares underlying stock options, excluding performance-based stock options, for the nine months ended July 31, 2014 were as follows:

Dollar amounts in thousands, except per share amounts	Shares		Weighted Average Price		Weighted Average Life	Aggregate Intrinsic Value
Outstanding, October 31, 2013	8,829,618		$	4.83
Granted	275,000		8.05
Exercised	(1,024,166	)	4.34			$	3,928
Canceled	(975,250	)	8.06
Outstanding, July 31, 2014	7,105,202		$	4.57	5.3	$	2,061
Options exercisable, July 31, 2014	5,802,200		$	4.24	4.7	$	2,061

Schedule of Changes in Non-Vested Shares under Option, Excluding Performance Based Options

Changes in non-vested shares underlying stock options, excluding performance-based stock options, for the nine months ended July 31, 2014 were as follows:

	Shares		Weighted Average Grant Date Fair Value
Non-vested, October 31, 2013	2,784,826		$	2.95
Granted	275,000		5.82
Vested	(1,651,824	)	2.24
Canceled	(105,000	)	4.71
Non-vested, July 31, 2014	1,303,002		$	4.28

Schedule of Restricted Stock Activity

Changes in restricted stock for the nine months ended July 31, 2014 were as follows:

	Shares
Outstanding, October 31, 2013	195,000
Granted	105,000
Vested	(95,000	)
Forfeited	(30,000	)
Outstanding, July 31, 2014	175,000